Albert Fried & Company logo

Albert Fried & Company

North America, New York, United States, New York

Description

Albert Fried & Company established itself as a Specialist Firm on the New York Stock Exchange while Wall Street.

Investor Profile

Albert Fried & Company has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Albert Fried & Company frequently co-invest with?

BC
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Lombard Odier
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Lurie Investment Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
NAI Elliott
North America, Oregon, United States, Portland
Co-Investments: 1
AI
North America, New York, United States, Greenport
Co-Investments: 1
Deutsche Bank
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
Perry Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Albert Fried & Company?

Palatin Technologies

Cranbury, New Jersey, United States

Palatin Technologies is a biopharmaceutical company developing targeted receptor specific peptide therapeutics to treat diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJan 30, 2004
Amount Raised: $22,700,000